Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of antidiabetic drugs such as DPP-4 inhibitors. Its structural configuration enables high selectivity and potency in targeting enzyme activity, contributing to improved glycemic control. The compound's fluorinated aromatic group enhances metabolic stability and bioavailability, making it valuable in optimizing drug efficacy. It is also employed in research for designing novel neuroactive compounds due to its ability to cross the blood-brain barrier and interact with central nervous system targets.